Patients on this drug are burdened by cost. How CT wants to bring prices down
After Bonnie had part of her thyroid removed, weight gain accompanied the aftermath of the procedure. The Connecticut…
orisang Thandekiso on her year-long healing journey
The media personality said she is grateful to God for saving her life. TV presenter Rorisang Thandekiso has…
Investigation launched into sale of illegal weight-loss medication in Wrexham and Flintshire
News • February 12, 2026 at 4:21 pm An investigation has been launched into illegal weight-loss medication allegedly…
UK faces shortage of medicine used by 12 million people ‘until June’
The UK faces a shortage until June UK faces shortage of medicine used by 12 million people ‘until…
Novo Nordisk Launches Wegovy in Vials to Compete
Written by Emily J. Thompson, Senior Investment Analyst Source: Benzinga Updated: 1h ago 0mins Source: Benzinga Intensifying Market…
Nektar, continuing comeback, says eczema drug’s effects hold up in follow-up study
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free…
Novo’s weight loss tablet attracts customers from competitors
I want to receive customized email newsletters from Watch Medier A/S , including information about our brands and…
Novo Nordisk to Launch Wegovy in Vials to Compete with Eli Lilly
Written by Emily J. Thompson, Senior Investment Analyst Source: seekingalpha Updated: 3h ago 0mins Source: seekingalpha Increased Market…
Many young people are being prescribed multiple psychiatric drugs at once, Penn study finds
The use of psychiatric medications to treat mental health and behavioral disorders in children and young adults has…
Novo Nordisk Reportedly Eyes Launching Wegovy In Vials To Compete With Rival Eli Lilly
(MENAFN– AsiaNet News) It is unclear what the company intends to charge for the vials, the report said.…
Novo Nordisk’s Wegovy launch faces competition; shares drop — TradingView News
Key facts: Novo Nordisk’s Wegovy launch faces competition; shares drop — TradingView News Deutsche Bank’s Emmanuel Papadakis highlighted…
More than a third of patients on Wegovy pill are new to GLP-1 drugs, study finds
Among ‌early users ​of Novo Nordisk’s new Wegovy weight-loss ‌pill, 36% had no prior experience taking a…